The Correlation of Prostatic Volume With Participants’ Age,Body Mass Index,Renal Ultrasonographic Findings,and Clinical Symptoms

Abstract

Objective:

To correlate the prostatic volume (PV) with the participants’ age, body mass index (BMI), clinical symptoms, and renal ultrasonographic findings.

Materials and Methods:

One hundred participants were enrolled in a quantitative prospective study from August 2024 to October 2024. They were selected through a random sample; the inclusion criteria included participants with renal or lower urinary tract symptoms (LUTS). Patients with prostatic tumors or who were unwilling to participate were excluded. All participants underwent a prostate sonogram. The transabdominal ultrasonographic images were obtained with the participant lying supine on an examination table. The prostate was evaluated for volume (PV) and echotexture. A chi-square test, Pearson’s correlations, and univariate regression analysis were conducted to determine statistical correlations.

Results:

The mean age of the participants was 41.8 ± SD 12.1 years, the mean cohort’s PV was 24.37 ± SD 18.1 cm³, and the mean cohort’s body mass index (BMI) was 27.9 ± SD 4.6 kg/m². There was significant strength of associations found between the PV and clinical findings, renal ultrasonographic findings, age, and BMI (p = .041, .001, .0001, and .038, respectively).

Conclusion:

Based on the results of this cohort study, PV may have a significant correlation with clinical symptoms, renal ultrasonographic findings, age, and BMI.

Keywords

Body mass index clinical symptoms prostate ultrasonography

Get full access to this article

View all access options for this article.

References

Brakohiapa

Botwe

Sarkodie

. Prostatic volume determination by transabdominal ultrasonography: does accuracy vary significantly with urinary bladder volumes between 50 to 400 mL. J Med Radiat Sci. 2019;66(2):81–90. doi:10.1002/jmrs.320.

Mallik

Rahman

Karmaker

, et al: Correlation of prostate volume, uroflowmetry variables and BMI in patients having clinical benign prostatic hyperplasia. KYAMC J. 2024;14(3):138–144. doi:10.3329/kyamcj.v14i03.68562.

Anon: Prostate volume and PSA density calculator. Radiogyan. Published 2023. Accessed May 18, 2025. https://radiogyan.com/prostate-volume-and-psa-density-calculator/.

Sandhu

Bixler

Dahm

, et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2023;211(1):11–19. doi:10.1097/ju.0000000000003698.

Bhat

Rather

Islam

. An overview of benign prostatic hyperplasia and its appreciation in Greco-Arab (Unani) system of medicine. Asian J Urol. 2021;9(2):109–118. doi:10.1016/j.ajur.2021.05.008.

Strand

Costa

Francis

Ricke

Roehrborn

. Targeting phenotypic heterogeneity in benign prostatic hyperplasia. Differentiation. 2017;96:49–61. doi:10.1016/j.diff.2017.07.005.

Patel

Parsons

. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014;30(2):170–176. doi:10.4103/0970-1591.126900.

Bezinque

Moriarity

Farrell

Peabody

Noyes

Lane

. Determination of prostate volume. Acad Radiol. 2018;25(12):1582–1587. doi:10.1016/j.acra.2018.03.014.

Guo

Zhang

Jiao

, et al: Comparison of prostate volume measured by transabdominal ultrasound and MRI with the radical prostatectomy specimen volume: a retrospective observational study. BMC Urology. 2023;23(1):62. doi:10.1186/s12894-023-01234-5.

10.

Riyach

Ahsaini

Kharbach

, et al: Bilateral ureteral obstruction revealing a benign prostatic hypertrophy: a case report and review of the literature. J Med Case Rep. 2014;8(1):42. doi:10.1186/1752-1947-8-42.

11.

Tycoch

Wieczorek

: The standards of an ultrasound examination of the prostate gland. J Ultrasonography. 2016;16(67):378–390. doi:10.15557/jou.2016.0038.

12.

Weir

Jan

: BMI classification percentile and cut off points. Published 2023. Accessed May 17, 2025. https://www.ncbi.nlm.nih.gov/books/NBK541070/.

13.

Udo

Robinson

Ijeruh

, et al: Correlation between prostate volume and lower urinary tract symptoms: a hospital-based study. J Glob Radiol. 2024;10(1):679. doi:10.7191/jgr.679.

14.

Iqbal

Uzair

Khadija

, et al: Frequency of urinary tract abnormalities on ultrasound with benign prostatic hyperplasia. Pak Biomed J. 2022;5:82–85. doi:10.54393/pbmj.v5i4.359.

15.

Awaisu

Ahmed

Lawal

, et al: Correlation of prostate volume with severity of lower urinary tract symptoms as measured by international prostate symptoms score and maximum urine flow rate among patients with benign prostatic hyperplasia. Afr J Urol. 2021;27(1):16. doi:10.1186/s12301-021-00122-4.

16.

Daryanto

Afifah

Budaya

. Relationship between prostate volume and risk of chronic kidney disease (CKD) in benign prostate hyperplasia (BPH) patients after transurethral resection of the prostate (TURP): an observational study. J Indonesian Med Assoc. 2024;74(3):114–121. doi:10.47830/jinma-vol.74.3-2024-1420.

17.

Meng

Liu

Guan

, et al: Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: evidence from 5285 patients. Int J Clin Pract. 2019;73(12):13438. doi:10.1111/ijcp.13438.

18.

Situmorang

Ginting

Chairul

MCM

. Correlation of age factors with incidence rates of benign enlarged prostate disease at Royal Prima RSU in 2022. J Multidisp Indonesia. 2023;2(12):3546–3551. doi:10.58344/jmi.v2i11.842.

19.

Aigbe

Ogbetere

. Relationship between prostate volume, age and body mass index among patients with benign prostatic hyperplasia in the Niger Delta region, Nigeria. Afr Urol. 2022;2(1):32–34. doi:10.36303/auj.2022.2.1.0026.

20.

Kowalczyk

Gołuch

Armata

, et al: Volume of the normal prostate gland in Polish boys, aged 1-17 years: based on transabdominal ultrasound: prospective study. J Pediatr Urol. 2024;20:468–474. doi:10.1016/j.jpurol.2023.12.007.

21.

Deng

Huang

Weng

Zeng

: Body mass index and risk of prostate volume, international prostate symptom score, maximum urinary flow rate, and post-void residual in benign prostatic hyperplasia patients. Am J Mens Health. 2019;13(4):870382. doi:10.1177/1557988319870382.

22.

Negi

Desai

Faujdar

, et al: The correlation between obesity and prostate volume in patients with benign prostatic hyperplasia: a prospective cohort study. Urologia. 2024;91(3):512–517. doi:10.1177/03915603241240645.

23.

Omran

Leca

Oštarijaš

, et al: Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors. Ther Adv Endocrinol Metab. 2021;12:1066210. doi:10.1177/20420188211066210.

24.

Tritanto

Arifin

Prajitno

Correlation of body mass index with prostate volume in benign prostatic hyperplasia patients. J Widya Med Jr. 2021;3(1):19–31. doi:10.33508/jwmj.v3i1.3005.

25.

Mampa

Haffejee

Fru

The correlation between obesity and prostate volume in patients with benign prostatic hyperplasia at Charlotte Maxeke Johannesburg Academic Hospital. Afr J Urol. 2021;27:60. doi:10.1186/s12301-021-00160-y.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.02 MB

0.11 MB

0.00 MB

0.12 MB